Eli Lilly wins FDA label update for Alzheimer’s drug (LLY:NYSE) - Seeking Alpha
3 hours ago • Google News
Eli Lilly and Company (LLY)
US$ 738.05992.14%
Price Chart
Key Statistics
Market Cap
$ 698.13B
P/E Ratio
62.92
Revenue (TTM)
$ 49B
Volume
4.72M
52W High
$ 967.27
52W Low
$ 675.71
Dividend Yield
0.77%
Beta
0.39
Technicals
50-Day MA
776.72
200-Day MA
815.8237
52 Week High
967.2689
52 Week Low
675.705
About LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H.
Employees
47000
Headquarters
Indianapolis, IN
CEO
Mr. David A. Ricks
Latest News
Eli Lilly (LLY) Announced Results for its Once-Weekly Insulin - Insider Monkey
9 hours ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
32.36
Percentile: 70.22
Environmental Risk Score
0.63
Percentile: 1
Social Risk Score
16.68
Percentile: 1
Governance Risk Score
13.31
Percentile: 1
Controversy Level
ESG data provided by Sustainalytics, Inc.
LLY
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg